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Aims:
  To
  determine
  the
  degree
  to
  which
  cigarette
  smoking
  predicts
  levels
  of
  cannabis
  dependence
  above
and
 beyond
 cannabis
 use
 itself,
 concurrently
 and
 in
 an
 exploratory
 four-year
 follow-up,
 and
 to
 investigate
whether
  cigarette
  smoking
  mediates
  the
  relationship
  between
  cannabis
  use
  and
  cannabis
  dependence.
Methods:
  The
  study
  was
  cross
  sectional
  with
  an
  exploratory
  follow-up
  in
  the
  participants’
  own
  homes
  or
via
  telephone
  interviews
  in
  the
  United
  Kingdom.
  Participants
  were
  298
  cannabis
  and
  tobacco
  users
  aged
between
  16
  and
  23;
  follow-up
  consisted
  of
  65
  cannabis
  and
  tobacco
  users.
  The
  primary
  outcome
  variable
was
  cannabis
  dependence
  as
  measured
  by
  the
  Severity
  of
  Dependence
  Scale
  (SDS).
  Cannabis
  and
  tobacco
smoking
  were
  assessed
  through
  a
  self-reported
  drug
  history.
Results:
  Regression
  analyses
  at
  baseline
  showed
  cigarette
  smoking
  (frequency
  of
  cigarette
  smoking:
B
 =
 0.029,
  95%
  CI
 =
 0.01,
  0.05;
  years
  of
  cigarette
  smoking:
  B
 =
 0.159,
  95%
  CI
 =
 0.05,
  0.27)
  accounted
  for
  29%
of
  the
  variance
  in
  cannabis
  dependence
  when
  controlling
  for
  frequency
  of
  cannabis
  use.
  At
  follow-up,
only
  baseline
  cannabis
  dependence
  predicted
  follow-up
  cannabis
  dependence
  (B
 =
 0.274,
  95%
  CI
 =
 0.05,
0.53).
  At
  baseline,
  cigarette
  smoking
  mediated
  the
  relationship
  between
  frequency
  of
  cannabis
  use
  and
dependence
  (B
 =
 0.0168,
  95%
  CI
 =
 0.008,
  0.288)
  even
  when
  controlling
  for
  possible
  confounding
  variables
(B
 =
 0.0153,
  95%
  CI
 =
 0.007,
  0.027).
Conclusions:
  Cigarette
  smoking
  is
  related
  to
  concurrent
  cannabis
  dependence
  independently
  of
  cannabis
use
  frequency.
  Cigarette
  smoking
  also
  mediates
  the
  relationship
  between
  cannabis
  use
  and
  cannabis
dependence
  suggesting
  tobacco
  is
  a
  partial
  driver
  of
  cannabis
  dependence
  in
  young
  people
  who
  use
cannabis
  and
  tobacco.
©
  2015
  The
  Authors.
  Published
  by
  Elsevier
  Ireland
  Ltd.
  This
  is
  an
  open
  access
  article
  under
  the
  CC
  BY
license
  (http://creativecommons.org/licenses/by/4.0/).
1.
  Introduction
Together,
 cannabis
 and
 tobacco
 are
 two
 of
 the
 world’s
 most
 used
drugs,
  and
  despite
  their
  unique
  smoking
  relationship,
  relatively
  lit-
tle
  is
  known
  about
  their
  combined
  effects.
  The
  high
  prevalence
  of
cannabis
 use
 amongst
 young
 people
 in
 the
 UK
 is
 a
 growing
 concern.
However,
  many
  daily
  cannabis
  users
  do
  not
  develop
  dependence.
Prospective
  studies
  of
  the
  likelihood
  of
  developing
  a
  Cannabis
Use
  Disorder
  (CUD)
  have
  investigated
  predictors
  of
  dependence
amongst
  cannabis
  users
  (Swift
  et
  al.,
  2000;
  van
  der
  Pol
  et
  al.,
  2013)
with
  baseline
  severity
  of
  dependence
  acting
  as
  a
  main
  predictor
of
  dependence
  at
  one-year
  follow-up
  (Swift
  et
  al.,
  2000).
  How-
ever,
  there
  are
  a
  host
  of
  other
  factors
  which
  have
  been
  considered
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predictors
  of
  developing
  a
  CUD,
  for
  example;
  age
  of
  onset
  (Chen
et
  al.,
  2005),
  gender
  (Coffey
  et
  al.,
  2000;
  von
  Sydow
  et
  al.,
  2002),
impulsivity
  (Swift
  et
  al.,
  2008),
  mental
  health
  problems
  (Wittchen
et
  al.,
  2007)
  and
  early
  onset
  of
  continued
  tobacco
  smoking
  (Coffey
et
 al.,
 2000;
 Prince
 van
 Leeuwen
 et
 al.,
 2014;
 von
 Sydow
 et
 al.,
 2002).
More
  recently,
  van
  der
  Pol
  et
  al.
  (2013)
  investigated
  a
  population
  of
high
  risk
  young
  adult
  cannabis
  users
  and
  found
  that
  recent
  nega-
tive
  life
  events
  and
  social
  support
  factors
  such
  as
  living
  alone
  were
more
  predictive
  of
  CUD
  then
  cannabis
  exposure
  variables
  suggest-
ing
  the
  existing
  literature
  on
  the
  aetiology
  of
  cannabis
  use
  disorder
is
  limited.
Relatively,
  tobacco
  is
  more
  harmful
  than
  cannabis
  (Nutt
  et
  al.,
2010)
  and
  the
  majority
  of
  tobacco
  smokers
  are
  indeed
  nicotine
dependent.
  The
  gateway
  hypothesis
  posits
  that
  tobacco
  acts
  as
  a
gateway
  drug
  to
  the
  use
  of
  cannabis
  (Kandel
  et
  al.,
  1992).
  However,
there
 is
 strong
 evidence
 for
 the
 ‘reverse
 gateway’
 whereby
 cannabis
smoking
 predicts
 tobacco
 onset
 (Patton
 et
 al.,
 2005).
 Several
 lines
 of
http://dx.doi.org/10.1016/j.drugalcdep.2015.01.004
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investigation
  give
  weight
  to
  the
  hypothesised
  association
  between
cannabis
 use
 and
 tobacco
 smoking.
 Firstly,
 there
 is
 evidence
 to
 sug-
gest
 both
 nicotine
 and
 cannabis
 affect
 similar
 mesolimbic
 dopamin-
ergic
  pathways
  suggesting
  overlapping
  mechanism
  in
  addiction
(David
  et
  al.,
  2005;
  Filbey
  et
  al.,
  2009).
  Secondly,
  there
  are
  shared
genetic
  (Agrawal
  et
  al.,
  2008,
  2010),
  temperamental
  (Brook
  et
  al.,
2010;
  Creemers
  et
  al.,
  2009)
  and
  psychological
  factors
  (Brook
  et
  al.,
2010)
  that
  have
  been
  associated
  with
  the
  use
  of
  both
  drugs.
  Finally,
both
  substances
  are
  smoked
  and
  often
  concurrently,
  such
  that
cross-sensitisation
  to
  each
  substance
  might
  occur,
  with
  tobacco
directly
  enhancing
  the
  subjective
  effect
  of
  cannabis
  (Agrawal
  and
Lynskey,
  2009;
  Baggio
  et
  al.,
  2013;
  Ream
  et
  al.,
  2008).
  As
  nicotine
  is
more
  addictive
  than
  cannabis,
  tobacco
  smoking
  may
  be
  a
  primary
driver
  of
  continued
  use
  and
  relapse
  in
  co-dependent
  users.
About
  90%
  of
  cannabis
  users
  also
  identify
  as
  cigarette
  smokers
(Agrawal
  et
  al.,
  2012),
  however,
  this
  exists
  as
  a
  complicated
  rela-
tionship
  given
  that
  increased
  cigarette
  smoking
  may
  substitute
  for
reduced
  cannabis
  consumption
  (Allsop
  et
  al.,
  2014)
  and
  vice
  versa.
Users
  of
  both
  drugs
  report
  more
  severe
  symptoms
  of
  CUD
  (Peters
et
  al.,
  2012).
  Half
  of
  adults
  seeking
  treatment
  for
  CUD
  also
  smoke
cigarettes
  and
  treatment
  outcomes
  for
  those
  using
  both
  cannabis
and
  tobacco,
  in
  comparison
  to
  cannabis
  alone,
  are
  poor
  (Agrawal
et
  al.,
  2009).
  Moreover,
  relative
  to
  those
  with
  a
  CUD,
  those
  with
co-occurring
  nicotine
  dependence
  show
  poorer
  psychiatric
  and
psychosocial
  outcomes
  (Peters
  et
  al.,
  2014;
  Ramo
  et
  al.,
  2013).
  In
a
  recent
  controlled
  laboratory
  study,
  Haney
  et
  al.
  (2012)
  found
  that
the
  strongest
  predictor
  of
  relapse
  in
  cannabis
  dependent
  individ-
uals
  was
  their
  cigarette
  smoking
  status.
  Further,
  cigarette
  smoking
ad
 libitum
 or
 after
 a
 short
 period
 of
 abstinence
 were
 both
 associated
with
  relapse
  to
  cannabis
  use
  thus
  ruling
  out
  acute
  nicotine
  expo-
sure
  or
  conditioned
  motivation
  (i.e.,
  transfer)
  effects.
  This
  study
suggests
  that
  cigarette
  smoking
  alongside
  cannabis
  use
  may
  confer
a
  greater
  dependence
  syndrome
  and
  therefore
  a
  greater
  likelihood
to
  relapse.
To
  understand
  the
  factors
  involved
  in
  the
  maintenance
  of
  sub-
stance
  use,
  such
  that
  prevention
  strategies
  are
  better
  informed,
longitudinal
  designs
  of
  the
  use
  of
  both
  drugs
  are
  essential,
  espe-
cially
  during
  the
  critical
  period
  of
  adolescence.
  The
  present
  study
aimed
 to
 investigate
 the
 degree
 to
 which
 cigarette
 smoking
 predicts
the
  level
  of
  cannabis
  dependence
  above
  and
  beyond
  cannabis
  use
itself,
 both
 at
 baseline,
 and
 in
 an
 exploratory
 four-year
 follow-up
 in
a
  sample
  of
  young
  cannabis
  and
  tobacco
  users.
  Cigarette
  smoking
at
  baseline,
  independently
  of
  smoking
  cannabis,
  is
  hypothesised
to
  contribute
  to
  CUD
  concurrently
  and
  at
  follow
  up.
  Moreover,
following
  previous
  research
  (Haney
  et
  al.,
  2012)
  we
  aimed
  to
investigate
  if
  the
  effects
  of
  cannabis
  use
  on
  cannabis
  depend-
ence
  are
  mediated
  by
  tobacco
  smoking
  using
  a
  multiple
  mediator
model.
2.
  Methods
2.1.
  Design
  and
  participants
2.1.1.
  Baseline.
  A
  sample
  of
  298
  cannabis
  users
  who
  also
  used
  tobacco
  (≥1
day/month)
  were
  selected
  from
  a
  sample
  comprising
  of
  over
  400
  recreational
  (1–24
days/month)
  and
  daily
  (≥25
  days/month)
  users
  aged
  16–23
  years
  old,
  as
  described
elsewhere
  (Freeman
  et
  al.,
  2014;
  Morgan
  et
  al.,
  2012).
  Inclusion
  criteria
  were
  (a)
  to
speak
  English
  ﬂuently,
  (b)
  not
  to
  have
  learning
  impairments,
  (c)
  to
  have
  no
  history
of
  psychotic
  illnesses
  and
  (d)
  normal
  or
  corrected-to-normal
  vision.
  All
  participants
provided
  written,
  informed
  consent.
  Participants
  could
  also
  consent
  to
  be
  contacted
for
  further
  studies
  and
  provided
  contact
  details
  as
  such.
  The
  study
  was
  approved
  by
the
  UCL
  Ethics
  Committee
  and
  its
  aims
  were
  supported
  by
  the
  UK
  Home
  Ofﬁce.
2.1.2.
  Procedure.
  Baseline
  measures
  were
  collected
  in
  participants’
  homes
  as
  part
of
  a
  larger
  study
  investigating
  acute
  cannabis
  effects.
  Participants
  were
  required
  to
abstain
  from
  all
  recreational
  drugs
  including
  alcohol
  for
  24
 h
  before
  each
  test
  day.
Demographic
  information,
  a
  drug
  history
  and
  assessment
  of
  CUD,
  via
  the
  Severity
of
  Dependence
  Scale
  (SDS;
  Gossop
  et
  al.,
  1995),
  were
  completed
  while
  participants
were
  abstinent.
  Participants’
  past
  use
  of
  cannabis
  and
  tobacco
  were
  assessed
  using
a
  semi-structured,
  questionnaire-based
  interview
  which
  included
  the
  following
Identi
 fied through ba
  seli
 ne 
databas
  e that con
  sen
  ted 
  and 
provided detail
  s for futur
  e 
contact (n= 34
  1)
Excluded (n= 234): 
- In
  correct
   contact
   details
   (n
  = 88) 
- Decli
  ned
   to partici
  pate
   (n= 10) 
- Agree
  d to parti
 cipate bu
  t could 
not be 
  contac
  ted
   (n
  = 16) 
- Never repli
 ed (n=
   117) 
- Other (n= 3) 
Successfully
   contacted
   and 
inter
  viewed
   (n=
   107) Excluded (n=
   42)
  : 
- Not re
  gular tobac
  co users a
  t 
baseli
  ne (n= 24) 
- Not re
  gular cann
  abis us
  ers 
  at 
baseli
  ne (n= 3)
   
- Data miss
  ing
   (n
  =15)  Analy
  sed (n= 65) 
Fig.
  1.
  Participant
  ﬂow
  diagram
  for
  opportunistic
  follow
  up,
  4
  years
  after
  baseline.
questions:
  (a)
  when
  did
  you
  last
  use
  tobacco?
  (b)
  For
  how
  many
  years
  have
  you
smoked
  tobacco?
  (YEARS-TOB)
  (c)
  In
  a
  typical
  month,
  how
  many
  days
  do
  you
  use
tobacco?
  (DAYS-TOB)
  (d)
  How
  many
  cigarettes
  do
  you
  smoke
  per
  day?
  (e)
  When
did
  you
  last
  use
  cannabis?
  (f)
  For
  how
  many
  years
  have
  you
  used
  cannabis?
  (g)
  In
a
  typical
  month,
  how
  many
  days
  do
  you
  use
  cannabis?
  (DAYS-CANNABIS)
  (h)
  How
long
  does
  it
  take
  you
  to
  smoke
  an
  eighth
  (3.5
 g)?
Participants
  were
  assessed
  for
  cannabis
  dependence
  using
  the
  SDS
  which
  is
ﬁve-item
  questionnaire
  focusing
  on
  ‘loss
  of
  control’
  or
  ‘psychological
  dependence’
in
  relation
  to
  cannabis
  use.
  It
  has
  good
  and
  well-established
  psychometric
  prop-
erties
  and
  was
  found
  to
  be
  of
  equal
  utility
  in
  diagnosing
  cannabis
  dependence
  in
comparison
  to
  more
  formal
  diagnostic
  assessments
  (Swift
  et
  al.,
  1998).
  A
  score
of
  three
  on
  the
  SDS
  indicates
  cannabis
  dependence
  (Swift
  et
  al.,
  1998).
  The
  fol-
lowing
  measures
  were
  also
  administered;
  (a)
  the
  Wechsler
  Test
  of
  Adult
  Reading
(WTAR;
  Wechsler,
  2001)
  which
  is
  a
  measure
  of
  premorbid
  verbal
  intelligence
  (IQ)
and
  consists
  of
  50
  irregularly
  spelt
  words.
  Scores
  range
  from
  0
  to
  50;
  (b)
  the
  Schizo-
typal
 Personality
 Questionnaire
 (SPQ;
 Raine,
 1991)
 which
 is
 a
 74-item
 questionnaire
where
  higher
  scores
  indicate
  a
  greater
  schizotypal
  personality
  disorder
  severity;
  (c)
the
  State-Trait
  Anxiety
  Inventory
  (STAI;
  Spielberger,
  1983),
  only
  the
  20
  items
  from
the
  trait
  scale
  were
  administered
  with
  higher
  scores
  reﬂecting
  greater
  trait
  anxiety;
(d)
  the
  Barratt
  Impulsiveness
  Scale
  (BIS-11;
  Patton
  et
  al.,
  1995)
  which
  is
  a
  30
  item
questionnaire
  describing
  common
  impulsive
  behaviours,
  high
  scores
  reﬂect
  greater
impulsivity;
  (e)
  the
  Beck
  Depression
  Inventory
  (BDI;
  Beck
  et
  al.,
  1961)
  which
  is
  a
  21
item
  questionnaire
  indexing
  depression
  over
  the
  past
  week
  (a
  score
  of
  10
  indicates
mild
  depression)
  and
  (f)
  the
  Childhood
  Trauma
  Questionnaire
  (CTQ;
  Bernstein
  et
  al.,
2003)
  which
  is
  a
  28
  item
  questionnaire
  assessing
  history
  of
  abuse.
2.2.
  Follow
  up
At
  follow-up,
  four
  years
  later,
  we
  attempted
  to
  re-contact
  the
  341
  participants
who
  gave
  consent
  and
  invited
  them
  to
  participate
  in
  a
  semi-structured
  telephone
interview
  (see
  Fig.
  1
  for
  participant
  ﬂow
  diagram).
  The
  ﬁnal
  sample
  consisted
  of
  65
cannabis
  and
  tobacco
  smokers.
Participants
 were
 recruited
 through
 a
 preliminary
 email
 requesting
 their
 partic-
ipation.
  All
  participants
  gave
  informed
  consent
  by
  telephone
  and
  were
  entered
  into
a
  prize
  draw
  to
  win
  a
  tablet
  computer
  for
  participating.
  Telephone
  interviews
  were
conducted
  between
  October
  and
  December
  2013.
  Demographics,
  a
  drug
  history
  and
the
 SDS,
 to
 reassess
 participants
 for
 CUD,
 identical
 to
 the
 baseline
 assessments,
 were
collected.
2.3.
  Statistical
  analysis
All
 analyses
 were
 conducted
 in
 IBM
 Statistical
 Package
 for
 Social
 Sciences
 (SPSS),
V.21.
  Assumptions
  of
  no
  perfect
  multicollinearity
  (no
  rs
 ≥
 0.8),
  linearity,
  normally
distributed
  errors
  and
  homoscedasticity
  were
  not
  violated.
  Correlations
  were
  con-
ducted
  between
  cannabis
  dependence,
  predictors
  and
  possible
  confounders.
  At
baseline,
 linear
 regression
 was
 used
 to
 assess
 the
 predictive
 relationship
 of
 cannabis
variables
  on
  cannabis
  dependence.
  Tobacco
  smoking
  variables
  were
  added
  to
  the
regression
  model
  to
  establish
  whether
  they
  could
  explain
  signiﬁcant
  additional
variance
  in
  CUD.
  Questionnaire
  measures
  that
  correlated
  strongly
  with
  cannabis
dependence
  were
  then
  added
  to
  the
  model
  and
  ﬁnally
  variables
  that
  were
  not
  found
to
  be
  signiﬁcant
  as
  regression
  coefﬁcients
  were
  removed
  generating
  the
  most
  par-
simonious
  model
  (accounting
  for
  the
  greatest
  amount
  of
  variance
  with
  the
  least
number
  of
  variables).
  Those
  predictors
  were
  then
  used
  to
  predict
  cannabis
  depend-
ence
  in
  the
  follow
  up
  data.
  Unstandardised
  B
  coefﬁcients
  are
  presented
  with
  2
decimal
  places.
We
  used
  PROCESS
  for
  Statistical
  Package
  for
  Social
  Sciences
  (SPSS)
  version
21
  (Hayes,
  2013;
  Preacher
  and
  Hayes,
  2008).
  Multiple
  mediation
  analyses
  were
conducted
  on
  a
  priori
  hypotheses.
  We
  tested
  the
  possible
  indirect
  effects
  ofC.
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  167
DAYS-CANNABIS
  on
  CANNABIS
  DEPENDENCE
  (SDS
  score)
  through
  tobacco
  smoking
variables
  (YEARS-TOB
 +
 DAYS-TOB)
  in
  a
  multiple
  mediator
  model
  whist
  controlling
for
  confounding
  variables
  in
  the
  baseline
  data.
  This
  method
  parses
  the
  relation-
ship
  between
  a
  predictor
  and
  an
  outcome
  into
  ‘indirect’
  and
  ‘direct’
  effects.
  Indirect
effects
  occur
  when
  the
  predictor
  inﬂuences
  the
  outcome
  variable
  through
  another
mediator
  variable.
  Multiple
  mediators
  have
  a
  combined
  and
  a
  speciﬁc
  (individ-
ual)
  contribution
  to
  the
  relationship
  between
  a
  predictor
  and
  outcome.
  In
  contrast,
‘direct
  effects’
  between
  the
  predictor
  and
  outcome
  are
  statistically
  independent
  of
this
  mediating
  relationship.
  For
  all
  analyses
  we
  used
  bias
  corrected
  95%
  conﬁdence
intervals
  (CI)
  which
  resulted
  from
  bootstrapping
  of
  10,000
  samples.
  An
  effect
  is
deemed
  signiﬁcant
  when
  the
  B
  lies
  within
  CIs
  that
  do
  not
  cross
  zero.
2.4.
  Missing
  data
For
 4
 participants,
 single
 questionnaire
 items
 for
 the
 SPQ
 (5
 individual
 responses
missing
  in
  total)
  were
  replaced
  with
  the
  mean
  of
  the
  subscale.
  SPQ
  data
  was
  missing
for
 11
 participants.
 For
 8
 participants,
 single
 questionnaire
 items
 for
 the
 BIS
 (10
 items
in
  total)
  were
  replaced
  with
  the
  mean.
  For
  the
  STAI,
  7
  items
  in
  total
  were
  replaced
with
  the
  mean.
  Thus,
  a
  total
  of
  0.05%
  of
  the
  baseline
  data
  was
  replaced
  with
  mean
scores.
3.
  Results
3.1.
  Baseline
  demographics
Participants
  in
  this
  study
  (N
 =
 298;
  71%
  male)
  were
  on
  average
20.55
 ±
 1.67
  years
  old
  with
  14.47
 ±
 1.94
  total
  years
  in
  education.
Their
  mean
  score
  on
  the
  BDI
  was
  7.27
 ±
 6.67
  with
  a
  range
  of
0–40
  (normative
  values;
  6.25
 ±
 4.00
  (Crawford
  et
  al.,
  2011)),
44
  participants
  (4.69%)
  scored
  >14
  (mild
  depression),
  STAI
39.41
 ±
 9.02
  (normative
  values;
  36.44
 ±
 10.93
  (Crawford
  et
  al.,
2011)),
  BIS
  70.73
 ±
 9.84
  (normative
  values;
  64.2
 ±
 10.70
  (Spinella,
2007)),
  WTAR
  41.93
 ±
 6.80,
  CTQ
  37.09
 ±
 10.04
  (normative
  val-
ues;
  98.63
 ±
 29.13
  (Paivio
  and
  Cramer,
  2004))
  SPQ
  (N
 =
 287)
17.67
 ±
 10.70
  (normative
  values;
  26.9
 ±
 11.00
  (Raine,
  1991)).
  139
(46.6%)
  participants
  met
  criteria
  for
  cannabis
  dependence
  (score
≥3
  on
  the
  SDS)
  at
  baseline.
3.2.
  Follow
  up
  demographics
The
 follow
 up
 sample
 (N
 =
 65;
 69.2%
 male)
 were
 a
 mean
 (SD)
 age
of
 24.66
 ±
 2.07.
 26.2%
 (N
 =
 17)
 met
 the
 criteria
 for
 cannabis
 depend-
ence
  at
  follow-up
  (further
  details
  of
  baseline
  demographics
  for
this
  group
  can
  be
  found
  in
  Table
  3).
  In
  comparison
  to
  the
  233
  who
were
  not
  followed
  up,
  the
  65
  who
  were
  did
  not
  differ
  signiﬁcantly
on
  age,
  gender,
  primary
  study
  variables
  or
  smoking
  characteristics
suggesting
  that
  the
  baseline
  demographics
  of
  the
  follow
  up
  group
are
  equivalent
  to
  the
  baseline
  group
  who
  were
  not
  followed
  up.
3.3.
  Correlations
  of
  primary
  baseline
  variables
  (Table
  1)
Correlations
  were
  conducted
  between
  the
  outcome
  variable
  of
SDS
  score
  (cannabis
  dependence),
  predictors
  and
  possible
  con-
founders
  (Table
  1).
  SDS
  correlated
  positively
  with
  scores
  on
  the
BDI
  (r
 =
 0.690,
  p
 =
 0.003).
  SDS
  correlated
  weakly
  with
  the
  WTAR
(r
 =
 −0.16,
  p
 =
 0.004)
  and
  also
  weakly
  with
  scores
  on
  the
  SPQ
(r
 =
 0.133,
  p
 =
 0.024)
  but
  not
  on
  the
  STAI
  (r
 =
 0.090,
  p
 =
 0.133)
  or
  BIS
(r
 =
 0.090,
  p
 =
 0.110).
  BIS
  scores
  correlated
  with
  cigarettes
  per
  day
(r
 =
 0.166,
  p
 =
 0.004)
  and
  days
  per
  month
  cannabis
  use
  (r
 =
 0.153,
p
 =
 0.008).
3.4.
  Regression
  analysis
  (Table
  2)
3.4.1.
  Cannabis
  only
  model.
  This
  model
  predicted
  24.6%
  of
  the
  vari-
ance
  in
  cannabis
  dependence.
  Cannabis
  dependence
  score
  was
signiﬁcantly
  predicted
  by
  DAYS-CANNABIS.
  Cannabis
  dependence
scores
  increased
  by
  0.12
  units
  for
  every
  extra
  day
  of
  cannabis
  use
per
 month.
 Time
 to
 smoke
 an
 eighth,
 years
 of
 cannabis
 use
 and
 days
since
 last
 cannabis
 use
 were
 not
 predictive
 of
 cannabis
 dependence.
3.4.2.
  Cannabis
 +
 tobacco
 model.
  When
 tobacco
 variables
 are
 added
to
  regression
  model,
  the
  model
  predicted
  28.5%
  of
  the
  variance
  in
cannabis
  dependence
  (R2 change
 =
 0.038,
  F
  change(4,298)
 =
 3.880,
p
 =
 0.004).
  DAYS-CANNABIS
  remained
  a
  signiﬁcant
  predictor
  of
cannabis
  dependence
  with
  dependence
  scores
  increasing
  0.1
units
  for
  every
  extra
  day
  per
  month.
  YEARS-TOB
  was
  predic-
tive
  of
  cannabis
  dependence.
  For
  every
  additional
  year
  of
  tobacco
smoking,
 cannabis
 dependence
 scores
 increased
 0.197
 units.
 DAYS-
TOB
  was
  a
  signiﬁcant
  predictor
  of
  cannabis
  dependence;
  scores
increased
  by
  0.031
  units
  for
  every
  additional
  day
  of
  tobacco
  use
  per
month.
  Time
  to
  smoke
  an
  eighth,
  years
  cannabis
  smoked
  and
  days
since
 last
 cannabis
 use
 were
 not
 predictive
 of
 cannabis
 dependence.
3.4.3.
  Cannabis,
  tobacco
 +
 confounders
  model.
  Variables
  that
  corre-
lated
  strongly
  with
  cannabis
  dependence
  scores
  were
  added
  to
the
  regression
  model.
  BDI
  score
  signiﬁcantly
  predicted
  cannabis
dependence.
  For
  every
  unit
  increase
  on
  the
  BDI,
  cannabis
dependence
  scores
  increased
  by
  0.046
  units.
  As
  such
  the
  model
predicted
  30.4%
  of
  the
  variance
  in
  cannabis
  dependence
  scores
  (R2
change
 =
 0.019,
  F
  change(2,287)
 =
 3.955,
  p
 =
 0.020).
Table
  1
Means,
  standard
  deviations
  and
  correlation
  coefﬁcients
  of
  the
  primary
  baseline
  study
  variables.
SDS
  Time
  to
  smoke
3.5
 g
DAYS-CANNABIS
  Years
  cannabis
used
Cannabis
  last
used
  (days)
DAYS-TOB
  YEARS-TOB
  Tobacco
  last
used
  (days)
Cigarettes
  per
day
SDS
  1.00
  −0.19** 0.50*** 0.14* −0.25*** 0.30*** 0.26*** 0.00
  0.20**
Time
  to
  smoke
  3.5
 g
  1.00
  −0.40*** −0.04
  0.18** −0.11
  0.00
  0.01
  −0.08
DAYS-CANNABIS
  1.00
  0.13* −0.46*** 0.33*** 0.18** 0.01
  0.24***
Years
  cannabis
used
1.00
  −0.17** 0.13* 0.59*** 0.09
  0.16**
Cannabis
  last
  used
(days)
1.00
  −0.16
  −0.07
  −0.02
  −0.10
DAYS-TOB
  1.00
  0.24*** −0.18** 0.44***
YEARS-TOB
  1.00
  −0.09
  0.19**
Tobacco
  last
  used
(days)
1.00
  −0.09
Cigarettes
  per
  day
  1.00
M
  2.85
  8.51
  18.50
  4.94
  3.76
  23.61
  4.70
  20.10
  7.17
SD
  2.73
  15.00
  10.68
  2.34
  6.05
  10.01
  2.53
  111.85
  5.86
* p
 <
 .05.
** p
 <
 .01.
*** p
 <
 .001.168
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Table
  2
Predicting
  cannabis
  dependence
  from
  cannabis
  exposure
  variables
  only,
  tobacco
exposure
  variables,
  and
  psychological
  correlates
  (confounders)
  to
  develop
  the
  most
efﬁcient
  model.
B
  BCa
95%
  CI
  (lower,
upper)
p
Cannabis
  only
R2 =
 0.246,
  p
 <
 0.001
Constant
  0.221
  −0.65,
  1.11
  0.632
Time
  to
  smoke
  3.5
 g 0.001 −0.02,
  0.23 0.929
DAYS-CANNABIS
  0.120
  0.09,
  0.15
  <0.001
years
  cannabis
  used
  0.090
  −0.03,
  0.21
  0.144
cannabis
  last
  used
  −0.012
  −0.06,
  0.03
  0.537
Cannabis
 +
 tobacco
R2 =
 0.285,
  F
 =
 23.93,
  p
 <
 0.001
Constant
  −0.400 −1.34,
  0.51 0.415
Time
  to
  smoke
  3.5
 g
  −0.002
  −0.02,
  0.18
  0.866
DAYS-CANNABIS
  0.101
  0.07,
  0.13
  <0.001
Years
  cannabis
  used
  −0.054
  −0.18,
  0.09
  0.407
Cannabis
  last
  used −0.020 −0.07,
  0.03 0.321
DAYS-TOB
  0.031
  0.00,
  0.06
  0.020
YEARS-TOB
  0.197
  0.06,
  0.32
  0.003
Tobacco
  last
  used
  0.001
  0.00,
  0.03
  0.174
Cigarettes
  per
  day
  0.010
  −0.04,
  0.07
  0.728
Cannabis,
  tobacco
 +
 confounders
R2 =
 0.304,
  F
 =
 12.52,
  p
 <
 0.001
Constant
  0.560 −1.30,
  2.30 0.552
Time
  to
  smoke
  3.5
 g
  −0.001
  −0.02,
  0.02
  0.934
DAYS-CANNABIS
  0.098
  0.07,
  0.13
  <0.001
Years
  cannabis
  used
  −0.022
  −0.15,
  0.11
  0.766
Cannabis
  last
  used
  −0.023
  −0.07,
  0.03
  0.363
DAYS-TOB
  0.030 0.00,
  0.06 0.057
YEARS-TOB
  0.175
  0.04,
  0.31
  0.012
Tobacco
  last
  used 0.001
  −0.05,
  0.05
  0.488
Cigarettes
  per
  day
  0.010
  −0.07,
  0.01
  0.984
WTAR
  −0.029
  0.01,
  0.40
  0.160
BDI
  −0.046
  0.00,
  0.09
  0.033
Most
  efﬁcient
  model
R2 =
 0.295,
  F
 =
 30.72,
  p
 <
 0.001
Constant
  −0.933
  −1.62,
  −0.28
  0.008
DAYS-CANNABIS
  0.107
  0.08,
  0.13
  <0.001
DAYS-TOB
  0.029
  0.01,
  0.05
  0.010
YEARS-TOB
  0.159
  0.05,
  0.27
  0.006
BDI
  0.050
  0.01,
  0.10
  0.020
3.5.
  Most
  efﬁcient
  model
When
  redundant
  predictors
  were
  removed
  from
  the
  analysis,
the
 model
 predicated
 29.5%
 of
 the
 variance
 in
 cannabis
 dependence,
which
 is
 not
 signiﬁcantly
 different
 from
 model
 3
 (cannabis,
 tobacco
+
  confounders)
  which
  includes
  cannabis,
  tobacco
  and
  potential
confounders
  (R2 change
 =
 0.090,
  F
  change(4,293)
 =
 0.008,
  p
 =
 0.750).
DAYS-CANNABIS
  remained
  the
  most
  important
  predictor
  of
cannabis
  dependence,
  followed
  by
  YEARS-TOB,
  DAYS-TOB
  and
  BDI
score.
  In
  this
  model,
  r
 =
 0.54
  for
  the
  most
  efﬁcient
  model
  which
  is
considered
  a
  large
  effect
  size
  (Cohen,
  1988).
3.6.
  Exploratory
  regression
  analysis
Demographic
  variables
  were
  added
  to
  the
  most
  efﬁcient
  given
the
  associations
  between
  these
  variables
  and
  CUD
  (as
  sex
  dif-
ferences
  have
  been
  reported
  in
  relation
  to
  abuse
  related
  effects;
Cooper
  and
  Haney,
  2014).
  When
  gender
  is
  added
  to
  this
  model,
  the
model
  predicts
  29.6%
  of
  the
  variance
  in
  cannabis
  dependence
  (R2
change
 =
 0.010,
  F
  change(1,292)
 =
 0.180,
  p
 =
 0.670).
Age
  was
  then
  added
  to
  the
  most
  efﬁcient
  model
  (without
  gen-
der).
  This
  model
  accounts
  for
  30.7%
  of
  the
  variance
  in
  cannabis
dependence
  (R2 change
 =
 0.011,
  F
  change(1,292)
 =
 4.740,
  p
 =
 0.030).
The
  addition
  of
  Age
  (B
 =
 0.198,
  95%
  BCI
 =
 0.037,
  0.368)
  correlated
highly
  with
  the
  variable
  YEARS-TOB,
  which
  was
  no
  longer
  signiﬁ-
cant
  when
  age
  was
  added
  (B
 =
 0.096,
  95%
  BCI
 =
 −0.035,
  −0.223).
Finally,
  scores
  on
  the
  CTQ
  were
  added
  to
  the
  regression
  model.
This
 model
 accounted
 for
 28.7%
 in
 the
 variance
 of
 cannabis
 depend-
ence
  (R2 change
 =
 0.001,
  F
  change(1,278)
 =
 0.440,
  p
 =
 0.510).
3.7.
  Exploratory
  follow-up
  analysis
3.7.1.
  Regression
  at
  follow-up
  (Table
  4).
3.7.1.1.
  Most
  efﬁcient
  model.
  The
  signiﬁcant
  predictors
  in
  the
  base-
line
 regression
 (Table
 2)
 were
 used
 to
 predict
 cannabis
 dependence
at
  follow-up,
  4
  years
  later.
  This
  was
  to
  gage
  whether
  the
  same
  fac-
tors
  that
  predict
  dependence
  at
  baseline
  can
  predict
  dependence
  at
follow
  up.
  Means,
  standard
  deviations
  and
  correlation
  coefﬁcients
of
  these
  variables
  can
  be
  found
  in
  Table
  3.
  This
  model
  predicted
18.5%
 of
 the
 variance
 in
 dependence
 at
 follow-up.
 DAYS-CANNABIS,
DAYS-TOB
  and
  YEARS-TOB
  and
  BDI
  score
  were
  not
  signiﬁcant
  pre-
dictors
  of
  cannabis
  dependence
  at
  follow
  up.
3.7.2.
  Most
  efﬁcient
  model
  accounting
  for
  baseline
  cannabis
  depend-
ence.
  Baseline
 cannabis
 dependence
 was
 added
 to
 the
 model
 stated
above.
  As
  a
  result,
  cannabis
  dependence
  became
  the
  only
  signiﬁ-
cant
  predictor
  of
  predicted
  cannabis
  dependence
  at
  follow-up
  (R2
change
 =
 0.062,
  p
 <
 0.031).
  This
  model
  predicted
  24.8%
  of
  the
  vari-
ance
  in
  dependence
  at
  follow-up.
3.8.
  Multiple
  mediation
  analysis
  (Fig.
  2)
As
  a
  result
  of
  DAYS-TOB
  and
  YEARS-TOB
  being
  signiﬁcant
  pre-
dictors
  of
  baseline
  cannabis
  dependence
  in
  the
  linear
  regression
(Table
  2),
  these
  variables
  were
  used
  a
  mediators
  in
  a
  multiple
mediator
  model
  to
  discern
  if
  the
  relationship
  between
  cannabis
Table
  3
Means,
  standard
  deviations
  and
  correlation
  coefﬁcients
  of
  the
  primary
  baseline
  study
  variables
  with
  follow
  up
  cannabis
  dependence
  (n
 =
 65).
Baseline
  Follow
  up
SDS
  DAYS-CANNABIS
  DAYS-TOB
  YEARS-TOB
  BDI
  SDS
Baseline
SDS
  1.00
  0.57*** 0.42** 0.29* 0.12
  0.37**
DAYS-CANNABIS
  1.00
  0.39** 0.29* 0.14
  0.26*
DAYS-TOB
  1.00
  0.31* 0.14
  0.23
YEARS-TOB
  1.00
  −0.07
  0.09
BDI
  1.00
  0.37**
Follow-up
  SDS
  1.00
M
  2.80
  19.25
  23.53
  5.25
  6.51
  1.40
SD
  2.64
  10.63
  9.93
  2.31
  5.59
  2.29
* p
 <
 .05.
** p
 <
 .01.
*** p
 <
 .001.C.
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Table
  4
Predicting
  cannabis
  dependence
  at
  follow
  up
  from
  variables
  that
  predicted
  baseline
cannabis
  dependence
  i.e.
  the
  most
  efﬁcient
  model
  and
  assessing
  whether
  they
  still
account
  for
  the
  model
  when
  cannabis
  dependence
  at
  baseline
  is
  added
  as
  a
  factor.
B
  BCa
95%
  CI
  (lower,
upper)
p
Most
  efﬁcient
  model
R2 =
 0.139,
  F
 =
 1.85,
  p
 <
 0.135
Constant
  −0.708
  −2.25,
  0.59
  0.409
DAYS-CANNABIS
  0.039
  −0.03,
  0.10
  0.164
DAYS-TOB
  0.010 −0.04,
  −0.06 0.748
YEARS-TOB
  0.042
  −0.19,
  0.28
  0.741
BDI
  0.137
  −0.44,
  0.32
  0.265
Most
  efﬁcient
  model
  accounting
  for
  baseline
  dependence
R2 =
 0.266,
  F
 =
 3.264,
  p
 <
 0.013
Constant
  −0.361
  −1.88,
  0.94
  0.668
DAYS-CANNABIS
  0.008
  −0.06,
  0.07
  0.770
DAYS-TOB
  −0.006
  −0.51,
  0.04
  0.852
YEARS-TOB
  0.014
  −0.21,
  0.25
  0.910
BDI
  0.138 −0.05,
  0.32 0.294
Baseline
  SDS
  0.274
  0.05,
  0.53
  0.023
use
  (DAYS-CANNABIS)
  and
  cannabis
  dependence
  (SDS
  score)
  was
mediated
  by
  concurrent
  tobacco
  use.
A
  bias-corrected
  and
  accelerated
  bootstrapped
  multiple
  medi-
ation
  model
  conﬁrmed
  the
  presence
  of
  a
  combined
  indirect
effect
  of
  DAYS-CANNABIS
  on
  cannabis
  dependence
  through
YEARS-TOB
 +
 DAYS-TOB
  (B
 =
 0.017,
  95%
  CI
 =
 0.008,
  0.288),
  with
  sig-
niﬁcant,
  speciﬁc
  indirect
  effects
  through
  YEARS-TOB
  (B
 =
 0.007
  95%
CI
 =
 0.002,
  0.016)
  and
  DAYS-TOB
  (B
 =
 0.010,
  95%
  CI
 =
 0.003,
  0.020)
(product
  of
  paths
  a
  and
  b
  in
  Fig.
  2).
  This
  model
  accounted
  for
28%
  of
  the
  variance
  in
  cannabis
  dependence,
  whereas
  the
  direct
effect
  of
  DAYS-CANNABIS
  on
  CANNABIS
  DEPENDENCE,
  accounted
for
  23%
  (direct
  B
 =
 0.108,
  95%
  CI
 =
 0.008,
  −0.028).
  Pairwise
  compari-
son
 between
 speciﬁc
 indirect
 effects
 was
 not
 signiﬁcant
 (B
 =
 −0.003,
95%
 CI
 =
 −0.014,
 0.008)
 suggesting
 that
 both
 YEARS-TOB
 and
 DAYS-
TOB
  are
  not
  statistically
  different
  from
  each
  other
  i.e.
  have
  equal
importance
  in
  mediating
  this
  relationship.
  The
  direct
  route
  (c
  and
c )
  suggests
  that
  when
  taking
  into
  account
  the
  mediating
  role
  of
tobacco
  smoking,
  DAYS-CANNABIS
  is
  still
  signiﬁcant.
3.9.
  Inﬂuence
  of
  confounds
Given
  that
  both
  BDI
  and
  WTAR
  correlated
  with
  dependence
at
  baseline,
  these
  were
  added
  as
  covariates
  into
  the
  above
  anal-
ysis.
  As
  such
  this
  model
  predicted
  30%
  of
  the
  variance
  in
  cannabis
dependence.
  The
  indirect
  effect
  of
  DAYS-CANNABIS
  on
  CANNABIS
DEPENDENCE
  through
  YEARS-TOB
  and
  DAYS-TOB
  whilst
  control-
ling
  for
  BDI
  and
  WTAR
  was
  signiﬁcant
  (B
 =
 0.015,
  95%
  CI
 =
 0.007,
0.027)
  with
  speciﬁc
  indirect
  effects
  through
  YEARS-TOB
  (B
 =
 0.007,
95%
  CI
 =
 0.002,
  0.015),
  and
  DAYS-TOB
  (B
 =
 0.009,
  95%
  CI
 =
 0.003,
0.018),
  with
  no
  signiﬁcant
  difference
  between
  DAYS-TOB
  and
YEARS-TOB.
  The
  direct
  effect
  of
  DAYS-CANNABIS
  on
  CANNABIS
DEPENDENCE
  when
  controlling
  for
  these
  covariates
  is
  still
  signiﬁ-
cant
  (B
 =
 0.105,
  95%
  CI
 =
 0.078,
  0.131).
4.
  Discussion
The
 main
 aim
 of
 this
 study
 was
 to
 investigate
 the
 role
 of
 cigarette
smoking
  on
  cannabis
  dependence,
  above
  and
  beyond
  the
  effects
  of
cannabis
  exposure,
  in
  a
  sample
  of
  young
  cannabis
  and
  tobacco
  co-
users.
  We
  conducted
  an
  exploratory
  follow-up
  of
  these
  users
  four
years
  later
  with
  a
  27%
  response
  rate
  of
  which
  70%
  of
  individuals
had
  smoked
  cannabis
  and
  tobacco
  at
  baseline.
  The
  65
  participants
that
 were
 followed
 up
 were
 equivalent
 in
 demographics
 and
 smok-
ing
  behaviour
  to
  those
  who
  were
  not
  followed
  up,
  at
  baseline.
  We
hypothesised
  that
  cigarette
  smoking
  would
  predict
  CUD,
  at
  both
time
  points.
  We
  also
  investigated
  whether
  the
  effects
  of
  cannabis
use
  on
  cannabis
  dependence
  were
  mediated
  by
  cigarette
  smoking.
Cigarette
  smoking
  at
  baseline
  was
  predictive
  of
  CUD
  at
  baseline
when
  controlling
  for
  cannabis
  use
  variables
  in
  young
  people
  who
smoke
  cannabis
  and
  tobacco.
  The
  most
  efﬁcient
  model
  accounted
for
  30%
  of
  the
  variance
  in
  cannabis
  dependence
  which
  is
  consid-
ered
  to
  be
  a
  large
  effect
  size
  as
  R
 >
 0.5
  (Cohen,
  1988).
  However,
this
  seems
  no
  longer
  the
  case
  four
  years
  later,
  where
  only
  base-
line
  CUD
  predicted
  follow-up
  CUD,
  accounting
  for
  almost
  25%
  of
the
  variance
  and
  replicating
  previous
  ﬁndings
  (Swift
  et
  al.,
  2000).
When
 we
 investigated
 how
 cigarette
 smoking
 predicted
 concurrent
CUD;
  we
  found
  that
  cigarette
  smoking
  (years
  of
  cigarette
  smoking
and
  days
  per
  month
  cigarette
  smoking)
  mediated
  the
  relationship
between
  cannabis
  use
  and
  cannabis
  dependence
  suggesting
  a
  role
of
  tobacco
  use
  in
  the
  pathogenesis
  of
  CUD
  in
  cannabis
  and
  tobacco
users.
  We
  also
  found
  these
  effects
  to
  be
  robust
  when
  controlling
for
  depression
  and
  premorbid
  IQ
  (which
  were
  found
  to
  be
  compa-
rable
  to
  normative
  values).
  Although
  causality
  cannot
  be
  assumed
in
  this
  cross-sectional
  analysis,
  these
  results
  suggest
  that
  cigarette
smoking
 may
 enhance
 the
 dependence-forming
 effects
 of
 cannabis.
Alternatively,
 our
 results
 may
 suggest
 that
 CUD
 (as
 measured
 by
 the
SDS)
  may
  capture
  some
  aspects
  of
  nicotine
  dependence
  in
  a
  subset
of
  young
  people
  with
  CUD.
  As
  such,
  this
  research
  supplements
  pre-
vious
  epidemiological
  research
  that
  stresses
  the
  predictive
  ability
of
  tobacco
  smoking
  in
  developing
  CUDs
  (Coffey
  et
  al.,
  2000;
  Prince
van
  Leeuwen
  et
  al.,
  2014;
  von
  Sydow
  et
  al.,
  2002).
Our
  results,
  based
  in
  a
  naturalistic
  setting,
  parallel
  results
  from
a
  recent
  controlled
  lab
  study
  that
  found
  cannabis
  users
  who
  smoke
cigarettes
  are
  more
  likely
  to
  relapse
  in
  comparison
  to
  those
  who
do
  not
  smoke
  cigarettes,
  perhaps
  as
  a
  result
  of
  this
  indirect
  path-
way
  (de
  Dios
  et
  al.,
  2009;
  Haney
  et
  al.,
  2012).
  As
  such,
  reducing
cannabis
  dependence
  might
  be
  facilitated
  by
  helping
  individuals
quit
  cigarette
  smoking
  (Macleod
  et
  al.,
  2004).
  We
  were
  able
  to
account
  for
  about
  30%
  of
  the
  variance
  in
  CUD
  from
  four
  predictor
variables.
 However,
 CUD
 is
 a
 complex
 disorder
 and
 causality
 cannot
be
  determined
  from
  one
  factor.
  There
  are
  many
  other
  factors
  that
can
  predict
  CUD
  that
  were
  beyond
  the
  scope
  of
  the
  current
  study
Fig.
  2.
  Multiple
  mediator
  model.
  Paths
  a,
  b,
  c
  and
  c  are
  OLS
  regression
  coefﬁcients
  in
  unstandardised
  form.
  Path
  c  represents
  the
  effect
  of
  x
  on
  y
  when
  tobacco
  variables
  (m)
are
  included
  as
  mediators.
  Path
  c
  represents
  the
  effect
  of
  x
  on
  y
  when
  the
  tobacco
  variables
  are
  not
  included
  as
  mediators.
  *p
 <
 .05,
  **p
 <
 .01,
  ***p
 <
 .001.170
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but
  have
  interesting
  implications.
  For
  example,
  a
  recent
  study
  by
van
  der
  Pol
  et
  al.
  (2013)
  found
  that
  current
  problems
  (such
  as
  liv-
ing
  alone,
  coping
  motives
  for
  cannabis
  use
  and
  negative
  life
  events)
were
  better
  predictors
  of
  cannabis
  dependence
  in
  young
  adults
than
  cannabis
  exposure
  itself.
  As
  a
  result
  of
  this
  study,
  we
  included
demographics
  and
  scores
  on
  the
  CTQ
  to
  our
  most
  efﬁcient
  model,
however
  these
  did
  not
  account
  for
  a
  signiﬁcant
  proportion
  of
  vari-
ance
  to
  be
  included
  in
  the
  ﬁnal
  model
  or
  in
  the
  mediation
  analysis.
It
  is
  clear
  that
  CUD
  is
  a
  complex
  disorder
  that
  has
  many
  predictors
and
  vulnerability
  factors
  that
  were
  not
  included
  in
  the
  model.
In
  the
  past,
  regular
  cigarette
  smoking
  would
  precede
  cannabis
use
  (Kandel
  et
  al.,
  1992).
  This
  sequence
  in
  drug
  use
  seems
  to
  be
tapering
  off,
  for
  example,
  around
  1
  in
  5
  young
  cannabis
  users
  have
never
  smoked
  a
  cigarette
  (Suris
  et
  al.,
  2007).
  Interestingly,
  both
cannabis
  and
  tobacco
  smoking
  were
  initiated
  4.9
  and
  4.7
  years
  pre-
viously,
  respectively,
  at
  the
  baseline
  visit,
  suggesting
  simultaneous
age
  of
  onset
  in
  the
  current
  study.
  Therefore,
  these
  results
  do
  not
speak
  to
  sequential
  use
  as
  on
  average
  the
  sample
  initiated
  both
substances
  at
  the
  same
  time.
Stricter
 tobacco
 laws
 in
 some
 countries
 have
 altered
 perceptions
such
  that
  cigarette
  smoking
  is
  considered
  a
  more
  risky
  behaviour
than
  previously.
  In
  2013,
  for
  the
  ﬁrst
  time,
  tobacco
  smoking
  preva-
lence
  was
  estimated
  to
  be
  below
  20%
  in
  the
  UK
  (Brown
  and
  West,
2014).
  In
  comparison,
  cannabis
  use
  has
  become
  normal
  and
  per-
ceptions
  of
  regular
  cannabis
  use
  as
  a
  risky
  behaviour
  are
  at
  an
all-time
  low
  (Johnston
  et
  al.,
  2013)
  with
  risk
  perception
  inversely
related
  to
  prevalence
  of
  cannabis
  use
  (Kleber
  and
  Dupont,
  2012).
This
  may
  be
  due
  to
  the
  shifting
  landscape
  and
  debate
  over
  legali-
sation
  of
  both
  medical
  and
  recreational
  marijuana
  in
  states
  such
  as
Colorado,
  California
  and
  Washington
  in
  the
  United
  States
  as
  well
as
  countries
  such
  as
  Uruguay
  and
  the
  Netherlands
  (Volkow
  et
  al.,
2014).
  As
  a
  result,
  whilst
  tobacco
  smoking
  decreases
  generally,
  it
is
  possible
  that
  tobacco
  use
  will
  also
  increase
  indirectly
  over
  time
due
  to
  increased
  cannabis
  use
  (Patton
  et
  al.,
  2005).
  Our
  ﬁndings
are
  timely
  because
  they
  suggest
  tobacco
  may
  be
  involved
  in
  the
pathogenesis
  of
  CUD,
  a
  possible
  risk
  factor
  of
  legalisation.
Our
 results
 may
 be
 a
 product
 of
 the
 common
 liability
 to
 the
 use
 of
cannabis
 and
 tobacco
 including
 such
 risk
 factors
 like
 shared
 genetic
and
 temperamental
 factors
 (Agrawal
 et
 al.,
 2008,
 2010;
 Brook
 et
 al.,
2010;
  Creemers
  et
  al.,
  2009).
  For
  example,
  recent
  research
  shows
that
  nicotine
  dependence
  was
  associated
  stronger
  with
  lifetime
CUD
  for
  females
  than
  males
  (Blanco
  et
  al.,
  2014).
  Moreover,
  Cooper
and
  Haney
  (2014)
  have
  recently
  demonstrated
  that
  whilst
  subjec-
tive
  effects
  are
  equal
  across
  genders,
  females
  report
  more
  abuse
related
  effects.
  Thus,
  an
  interesting
  analysis
  would
  be
  to
  investi-
gate
  whether
  the
  mediators
  suggested
  in
  the
  present
  study,
  were
stronger
  in
  females
  than
  males
  however,
  given
  that
  the
  sample
was
  71%
  male,
  this
  was
  not
  possible.
  Demographic
  variables
  were
instead
  added
  to
  the
  most
  efﬁcient
  model
  and
  we
  found
  that
  gen-
der
  and
  age
  did
  not
  predict
  cannabis
  dependence
  after
  accounting
for
  cannabis
  and
  tobacco
  use.
  Our
  results
  may
  also
  be
  a
  product
  of
the
  common
  route
  of
  administration
  (Agrawal
  and
  Lynskey,
  2009)
where
  inhalation
  of
  one
  substance
  may
  sensitise
  an
  individual
  to
the
  inhalation
  of
  another
  substance.
4.1.
  Strengths
  and
  limitations
This
  study
  has
  several
  strengths
  including
  a
  relatively
  large
sample
  size
  of
  298
  young
  cannabis
  and
  tobacco
  users
  assessed
  in
their
 own
 homes.
 Moreover,
 we
 used
 continuous
 variables
 to
 index
both
  cannabis
  and
  tobacco
  smoking
  making
  it
  possible
  to
  assess
the
  relationship
  between
  drug
  use
  variables
  at
  varying
  levels
  of
severity
  (Ramo
  et
  al.,
  2013).
  This
  study
  also
  suffers
  from
  several
limitations.
  First,
  within
  our
  exploratory
  follow-up
  sample
  we
  had
a
  modest
  response
  from
  65
  participants.
  This
  may
  have
  reduced
the
  power
  to
  detect
  a
  possible
  true
  effect
  of
  baseline
  cannabis
  use
on
  future
  dependence
  (for
  example,
  surprisingly,
  days
  of
  cannabis
use
  per
  month
  at
  baseline
  were
  not
  associated
  with
  cannabis
dependence
  at
  follow
  up)
  and
  therefore
  these
  exploratory
  follow-
up
  results
  should
  be
  interpreted
  with
  caution
  until
  they
  can
  be
replicated
  with
  a
  greater
  sample
  size.
  Moreover,
  we
  were
  unable
  to
control
  for
  the
  simultaneous
  use
  of
  cannabis
  and
  tobacco
  (joints)
as
  the
  route
  of
  administration
  and
  as
  a
  necessity
  our
  sample
  is
limited
  those
  who
  only
  smoke
  cannabis
  and
  tobacco.
  These
  results
should
  be
  interpreted
  within
  their
  self-reported
  context.
  Finally,
the
  multiple
  mediation
  analysis
  was
  conducted
  on
  cross
  sectional
data
  and
  therefore
  the
  existence
  and
  direction
  of
  causality
  cannot
be
  discerned.
4.2.
  Conclusions
In
  light
  of
  the
  medicalisation
  and
  legalisation
  of
  marijuana,
research
  on
  cannabis
  and
  tobacco
  use
  is
  essential.
  In
  a
  natural-
istic
  study
  of
  cannabis
  and
  tobacco
  co-users,
  baseline
  cigarette
smoking
  (frequency
  and
  years)
  predicts
  cannabis
  dependence
  con-
currently
  when
  controlling
  for
  frequency
  of
  cannabis
  use;
  however
this
  was
  no
  longer
  the
  case
  four
  years
  later.
  At
  baseline,
  cigarette
smoking
  mediated
  the
  relationship
  between
  cannabis
  use
  and
cannabis
  dependence,
  even
  when
  controlling
  for
  psychological
and
  demographic
  correlates
  that
  might
  explain
  this
  relationship.
This
  suggests
  that
  cigarette
  smoking
  enhances
  vulnerability
  to
  the
harmful
  effects
  of
  cannabis.
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